1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Welch Allyn

Discussion in 'Hill-Rom' started by anonymous, Dec 13, 2016 at 1:57 PM.

  1. anonymous

    anonymous Guest

    Any constructive insight as to where this division is at? Performing? Not Performing? Growth? Market share?

    Thanks